Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published October 10, 2012 | Version v1
Other Open

Letters to Cochrane - December 10th, 2012 - December, 8th, 2013 - December 23rd, 2013 - August 19th, 2014 - April 17th, 2017

  • 1. Re-Check
  • 2. Université de Lausanne
  • 3. McGill University
  • 4. Concordia University
  • 5. University of Waterloo, McMaster University
  • 6. Université de Montréal
  • 7. Université Laval

Description

Letters sent between 2012 and 2017 to the Cochrane Gynaecological, Neuro-oncology & Orphan Cancer Group (CGNOCG), senior editor of the HPV vaccines Cochrane review, and to Cochrane Editor in Chief David Tovey. These letters contain the analysis of Conflicts of Interest (COIs) in the review authors panel and point to methodological flaws in the review protocol. These letters have not been published. Cochrane communicated to us that received our letters and intervened on the most serious cases of conflicts of interest, dismissing some of the authors; in December 2013 the authors’ panel was indeed reconstituted. However, two authors, including the lead author, Marc Arbyn with COIs with Merck, Sanofi Pasteur MSD and GSK remained on the panel.

Files

2012-12-10_Letter_Cochrane.pdf

Files (1.2 MB)

Name Size Download all
md5:5e386ba73c9b7f85feb5053ea789abff
191.0 kB Preview Download
md5:4d8ff5a11ac03cb923c97b8fb1aaec58
429.6 kB Preview Download
md5:bd0ba3d0d39e5ad55960d416fd3b3e46
196.1 kB Preview Download
md5:9ff3e53e62a017063e6291643b781b2f
184.9 kB Preview Download
md5:4b52a6bc8fe3460c8b2bf6c3abd063ef
210.5 kB Preview Download